April 19, 2018

San Diego-based diagnostic lab testing company Biotheranostics Inc. agreed to pay $2 million to settle claims it violated the False Claims Act by submitting claims to Medicare for Breast Cancer Index (BCI) tests not reasonable and necessary for the diagnosis and treatment of breast cancer. DOJ

Tagged in: FCA Federal, Healthcare Fraud, Lack of Medical Necessity,